| 000 | 01257 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250518040513.0 | ||
| 264 | 0 | _c20200902 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a2284-0729 | ||
| 024 | 7 |
_a10.26355/eurrev_201904_17683 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Y-L | |
| 245 | 0 | 0 |
_aLncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p. _h[electronic resource] |
| 260 |
_bEuropean review for medical and pharmacological sciences _cApr 2019 |
||
| 300 |
_a3235-3242 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCell Cycle _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xgenetics |
| 650 | 0 | 4 |
_aDEAD-box RNA Helicases _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aRNA, Long Noncoding _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aHuang, Y-M | |
| 773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 23 _gno. 8 _gp. 3235-3242 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.26355/eurrev_201904_17683 _zAvailable from publisher's website |
| 999 |
_c29682901 _d29682901 |
||